IOVANCE BIOTHERAPEUTICS, INC. Available-for-sale Securities
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Available-for-sale Securities of $611.26 million as of 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2020-08-06
- 2020-06-30: Available-for-sale Securities $611.26M.
- 2020-03-31: Available-for-sale Securities $193.11M.
- 2019-12-31: Available-for-sale Securities $293.11M.
- 2019-09-30: Available-for-sale Securities $322.99M.
| Period end | Available-for-sale Securities |
|---|---|
| 2020-06-30 | $611.26M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $193.11M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $293.11M 10-Q · filed 2020-08-06 |
| 2019-09-30 | $322.99M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $327.24M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $385.93M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $386.37M 10-K · filed 2020-02-25 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-12 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 |
| 2017-06-30 | $14.73M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $40.10M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $59.75M 10-K · filed 2018-03-12 |
| 2016-09-30 | $86.39M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $70.60M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $60.25M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $70.11M 10-K · filed 2017-03-09 |
| 2015-09-30 | $79.37M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $92.30M 10-Q · filed 2015-08-10 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |